Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma.

Sci Rep · 2019 · PMC6753133 · PMID 31537857

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

showed a trendp = 0.055so close (0.05 < p ≤ 0.1)

Patients with poor performance status (ECOG > 1) showed a trend toward inferior OS (3-year OS 38% vs . 76% HR 2.767 [0.936–8.182], p = 0.055).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.